Vetter has added a flexible serialization service in response to stricter guidelines from regulatory authorities aimed at combatting counterfeit drugs. Vetter’s customizable solutions aim to serve as a basis for pharma and biopharma companies’ own track-and-trace programs to optimize their supply chain.   In some countries, such as Turkey, India, China, and Argentina, regulators already call for drugs to be serialized, and other markets will soon follow suit, including South Korea, Brazil,...